Paroxetine Tablet, Film Coated
Product Images NDC 70518-2871

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 70518-2871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of paroxetine hydrochloride showing the molecular arrangement of atoms, including the aromatic rings, oxygen, fluorine, nitrogen, and hydrochloride components.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A forest plot chart showing the fold change and 90% confidence intervals of pharmacokinetic parameters Cmax and AUC for various interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to a reference. The x-axis is labeled as 'Change relative to reference' on a logarithmic scale from 0.1 to 10.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC values of paroxetine when co-administered with various interacting drugs, including Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam. The x-axis measures change relative to reference from 0 to 2, with plotted points and error bars for each drug and parameter.*
FDA Label Image

Figure3.jpg (Figure3)

Figure3.jpg (Figure3)
A pharmacokinetic fold change chart showing Cmax, Cmin, and AUC values with 90% confidence intervals for paroxetine hydrochloride in populations with varying renal and hepatic impairment, different age groups (over 65 years) and doses (20 mg, 30 mg, 40 mg once daily), and gender (males). The x-axis represents change relative to reference on a logarithmic scale from 0.5 to 50.*
FDA Label Image

Mm1 (Paroxetine 20mg 70518 2871 00)

Mm1 (Paroxetine 20mg 70518 2871 00)
Paroxetine tablet packaging label showing 20 mg strength in a box of 100 tablets. The label includes the NDC number 70518-2871-00 and indicates the product is packaged by RemedyRepack Inc. The label also contains storage instructions, a QR code, and a note stating 'RX ONLY.' Tablets are described as oval and white.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
PARoxetine 20 mg film-coated tablet label showing the proprietary name, dosage strength, and quantity of 100 tablets. The label states the product is RX only and repackaged by RemedyRepack Inc. It includes manufacturer information (Apotex Corp., Weston, FL), NDC 70518-2871-00, a QR code, and storage directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.